To assess the association of Medicaid expansion with overall mortality among adults diagnosed with colorectal cancer.
Approach:
Study Design: A large national retrospective cohort study using a difference-in-differences (DID) framework.
Data Source: Utilized deidentified information from the National Cancer Database (NCDB), covering approximately 70% of newly diagnosed cancers in the US.
Cohort Characteristics: Included adults aged 40 to 64 years with histologically confirmed colorectal cancer diagnosed from January 1, 2006, through December 31, 2021.
Exposure Definition: Primary exposure was residence in a state that expanded Medicaid under the ACA.
Outcome Measures: Primary outcome was overall mortality; secondary outcomes included stage at diagnosis and receipt of cancer-directed treatment.
Key Findings:
Medicaid expansion was associated with improved insurance coverage and increased cancer screening rates.
There is limited evidence regarding the impact of Medicaid expansion on long-term survival in colorectal cancer patients.
Survival benefits associated with Medicaid expansion may differ based on disease stage and racial/ethnic group.
Interpretation:
The study investigates the relationship between Medicaid expansion and colorectal cancer mortality.
Limitations:
Study does not capture cause of death.
Exclusions based on missing data may affect generalizability.
Limited to adults aged 40 to 64 years, excluding older populations.
Conclusion:
The study seeks to fill evidence gaps regarding Medicaid expansion's impact on colorectal cancer survival.
